baber/WOPTO huggingface dataset:
Patent JP-H11502931-A (JP)
IPC: G01N30/36
Filed: 1996-03-07
Abstract: A syringe pump particularly adapted for delivery of small volumes at a high pressure in an accurate and reproducible manner. The syringe pump includes a frame, a motor attached to the frame, and a lead screw drivably connected to the motor. A cover seal is mounted to the front end of the lead screw, the cover seal having grooves formed therein to facilitate mounting and demounting of the cover seal. The pump further includes a cylindrical barrel within which the cover seal reciprocates, the barrel being made of a ceramic material, wherein the barrel is fixedly attached to the frame at the front end and floatably mounted to the frame at the back end. A barrel head is mounted to the front end of the barrel for closing off that end of the barrel, the barrel head including an outlet port for allowing fluid to enter and exit the barrel. In addition, the present invention includes a multi-syringe gradient syringe pump, a liquid chromatography system, a cover seal, and a mixer for mixing multiple flow streams.
Patent JP-H10500618-A (JP)
Title: 高温用途のための金属フィルター
IPC: C22C38/00
Filed: 1995-05-22
Abstract: (57)【要約】
Ｆe 3 Ａl相からＦeＡl相に対応する濃度範囲を有し、かつ約１．６以下のバブルポイントをもつ、鉄アルミニウムの合金組成物からなる焼結された金属粒子を含む改良耐腐食性を有する多孔質金属フィルターが提供される。
Patent JP-2000507359-A (JP)
Title: センサ素子及びその製造法
IPC: G01N27/409
Filed: 1997-11-29
Abstract: (57)【要約】
殊に内燃機関の排ガス中の酸素含量の測定のための小板状のセンサ素子（１０）が提案されている。このセンサ素子（１０）は、少なくとも１個の酸素イオン導通固形電解質を有する測定セル（１２）及び加熱素子（１４）を有しており、この場合、測定セル（１２）及び加熱素子（１４）は、電気絶縁層（５０）を介して互いに接続している。絶縁層（５０）の材料は、少なくとも１種の結晶性非金属性材料及び少なくとも１種のガラス形成材料からなり、この場合、センサ素子（１０）の焼結の際に結晶性非金属性材料で充填された釉が形成される。
Patent JP-H11503888-A (JP)
Title: 二重ポートｆｍ変調器用固定中継等化
IPC: H03C3/00
Filed: 1996-04-18
Abstract: (57)【要約】
標準二重ポート周波数変調器の高周波数ポートと低周波数ポートとの位相差によって引き起こされる不所望の効果を除去するための二重ポート周波数変調器及び方法。周波数変調器は、変調信号の高周波数成分を処理するための第１の高周波数ポート処理経路及び変調信号の低周波数成分を処理するための第２の低周波数ポート処理経路を含む変調器段の入力に結合された逆フィルタ段を含む。高周波数経路及び低周波数経路の出力は、電圧制御発振器の別々のポートに結合されている。逆フィルタのインパルス応答は、変調段のインパルス応答の逆に設計されている。フィルタは、二重ポート周波数変調器の全応答が顕著に改善される様に、変調器段の高及び低周波数処理経路内の遅延の差によって引き起こされた不所望の効果を打ち消す様に機能する。
Patent JP-2000506772-A (JP)
Title: 貴金属不含の触媒組成物
IPC: C01B15/029
Filed: 1997-03-05
Abstract: (57)【要約】
本発明は、ａ）ｉ）原子番号２１〜３２、３９〜４２、４８〜５１、５７〜７５及び８１〜８３を有する元素から選択された卑金属少なくとも１種の塩；ｉｉ）ホスフェートイオン及びｉｉｉ）少なくとも１種の窒素源を含有する水性混合物を製造し、ｂ）得られた水性混合物を蒸発させ、こうして形成された触媒組成物を、乾燥させることにより得られる貴金属不含の触媒組成物に関する。製造された触媒組成物は、過酸化水素の製造及びオレフィンのエポキシド化のために使用できる。
Patent JP-H11504450-A (JP)
IPC: G16H10/20
Filed: 1996-04-17
Abstract: A method of producing a document for regulatory approval of a medical product, comprising entering data objects pertaining to a study of the medical product into a database, providing a document format defining delimited data fields for insertion of data objects, providing a user interface for selection of the data objects to be included in the document, extracting data objects pertaining to the study from the database, using the extracted data objects as defined by the document format to generate the document compatible with a document publishing system, and publishing the generated document. The invention also relates to an apparatus for computer-aided composition and generation of a medical product document. <IMAGE>
Patent JP-H11505138-A (JP)
IPC: A61M1/36
Filed: 1996-05-08
Abstract: A method and device is described for direct removal of heparin from whole blood during extracorporeal therapy. In clinical situations where the blood is heparinized to prevent clotting in the extracorporeal circuit containing e.g., a hemodialysis cartridge or a heart-lung machine, it would be desirable to eliminate the systemic heparinization of the patients. The extracorporeal circuit contains a device having antithrombin III immobilized and inserted between the outlet port of the primary extracorporeal device, such as the hemodialysis cartridge or heart-lung machine and the patient. When the heparinized blood comes in contact with the immobilized antithrombin III, heparin is removed and the reperfused blood is substantially free of heparin. The advantage of the system lies in the fact that heparin is removed from the blood rather than neutralized. This helps overcome the adverse reactions and side effects associated with the use of heparin anticoagulation.
Patent JP-H11505365-A (JP)
Title: マルチフィラメント状超伝導性複合材料および製法
IPC: H01B13/00
Filed: 1996-05-17
Abstract: (57)【要約】
本発明はマルチフィラメント状超伝導性複合体物品(100)を提供するものであり、該物品は多数の実質的に電気的にデカップリングされたドメイン(106，108，110，112，114，116)を含み、その各々は、所定の超伝導性酸化物材料の、少なくとも一つの、好ましくは捩じれたフィラメント(130，132，134)を含む。好ましい態様においては、該物品(100)は、実質的に貴金属で構成されるマトリックス(104)、該マトリックス(104)を包囲する導電性ジャケット層(102)、複数の不連続なフィラメントデカップリング層(118，120，122，124，126，128，136)[該層各々は絶縁物質を含み、該マトリックス(104)内に配置されて、該マトリックス(104)を実質的に電気的にデカップリングされた複数のドメイン(106,108,110,112，114，116)に分離する〕、複数のフィラメント(130，132，134)(その各々は所定の超伝導性酸化物を含み、該マトリックス(104)内に配置されかつ該マトリックスに本質的に封入され、かつそれにより該デカップリング層(118，120，122，124，126，128，136)から化学的に分離されている)を含み、該電気的にデカップリングされたドメイン(106，108，110，112，114，116)は、各々少なくとも１本のフィラメント(130，132，134)を含む。本発明は、マルチフィラメント状物品(100)を与え、該物品はこれら材料として従来入手可能な任意のものよりも著しく優れた、高いDC性能およびAC性能を示す。該物品(100)の製法およびそのための中間体をも提供する。
Patent JP-2001511791-A (JP)
Title: ジカルボン酸結晶
IPC: C09K23/52
Filed: 1998-02-09
Abstract: (57)【要約】
ジカルボン酸結晶は、少なくとも１種の有機ジカルボン酸を含む溶液から、少なくとも２０００の分子量を有する少なくとも１種のアニオン性高分子電解質を、結晶化前又は結晶化中に添加する方法により製造される。
Patent JP-2000510779-A (JP)
Title: 圧縮可能なマンドレル上で不均衡に織られた繊維を巻くことにより得られる複合材料における管状の部材
IPC: B29C53/58
Filed: 1997-05-23
Abstract: (57)【要約】
本発明は、補強繊維の主要部分が構造の軸線に平行に置かれたような横糸不均衡に織られた繊維の適合した巻きにより生産される、軸性の圧縮又は曲げ圧力を受ける複合材料の管、パイル、マストを開示する。管、パイル及びマストは、圧縮可能なマンドレル上に巻くことにより生産され、管がマンドレルプラグが引き出された時に微少なクラックを受けたり圧迫されないことを確実にする。
Patent JP-2000515232-A (JP)
Title: 複数のスラストプレートを具えた流体軸受付きのスピンドル・モータ
IPC: F16C17/10
Filed: 1997-12-19
Abstract: (57)【要約】
円形シャフト部（94）によって分離される第１および第２のスラストプレート（90，92）を支承する固定の中央シャフト（59）を有する流体軸受カートリッジであり、各スラストプレートは、軸方向の表面によって連結する第１及び第２の半径方向の表面と、前記シャフトの中心軸により形成される中心回転軸線の周囲を固定シャフトに対して回転するスリーブ（72）とを有する。前記スリーブは、スラストプレートの各露出面に対向するカウンタプレート（105，107）を支持し、第１及び第２の各スラストプレート用の凹所を形成する。前記凹所は、軸方向の表面により連結する半径方向の表面を有し、各スラストプレートの周囲に連続した間隙(102)を形成するべくスラストプレートの半径方向及び軸方向の表面に対面する。前記間隙は前記シャフト、スリーブ及び前記スラストプレートの間、及び前記スリーブと前記カウンタプレートとの間に潤滑流体を有し、それによりスリーブはシャフトに対する高い剛性を維持しながら前記シャフトに相対的に動き得る。
Patent JP-2001523199-A (JP)
Title: 煙草用ヒンジ蓋付きボックス
IPC: B65D85/10
Filed: 1998-04-25
Abstract: (57)【要約】
この発明は、煙草またはその類似物用のヒンジ蓋付きボックスに関する。この発明によれば、ネック（１２）が、タブ手段（３４，３５）によって、ボックスの前面パネル（１３）の区域において主ブランク（３３）に接続される。前記ネックは、一続きのボックスの一部である。ネックの前面パネル（３０）は、タブ（３４，３５）の区域における複層構造の形成を避けるために凹部（４１，４２）を備える。前記のタブ（３４，３５）は折り曲げられてＺ字状を形成する。折り曲げられたタブ（３４，３５）の少なくとも一部がこれらの凹部（４１，４２）内に進入してこれらにフィットする。
Patent JP-2001527499-A (JP)
IPC: B66F7/02
Filed: 1999-03-19
Abstract: The invention is a lifting device, particularly for lifting a motorcycle or similar vehicle. The apparatus comprises a base member adapted to support the apparatus on a level surface, a support beam extending laterally from the base member, a lifting column attached to the far end of the support beam and projecting vertically from the support beam. The lifting apparatus is in engagement with the lifting column, and is adapted to be raised and lowered along the column. The lifting apparatus is configured with detachable mountings for engaging a motorcycle or similar vehicle as well as a mechanism for supporting the motorcycle's kick stand.
Patent JP-2002504270-A (JP)
Title: 整流接合を有する半導体デバイスおよび該半導体デバイスの製造方法
IPC: H01L29/885
Filed: 1999-04-01
Abstract: (57)【要約】
本発明は、逆の伝導タイプの２つの（半導体）領域（１、２）の間に位置する整流接合（５）を有する半導体デバイスに関する。第２の領域（２）は、シリコンを含み、シリコンとゲルマニウムの混合結晶を有するサブ領域を含む第１の領域（１）よりも厚さが小さく、かつ、小さい注入濃度を有する。これらの２つの領域（１、２）は、接続導体（３、４）をそれぞれ備えている。このようなデバイスは、スイッチング素子、特に高電圧および高電力の双方またはいずれか一方のスイッチング素子として使用されるのに非常に適している。公知のデバイスでは、シリコン−ゲルマニウム混合結晶が弛緩し、不整合転位の形成につながる。これらは、少数電荷キャリアの寿命を減少させるように働き、これにより、デバイスを非常に高速にスイッチングさせることができる。本発明によるデバイスでは、第１の領域（１）全体がシリコンとゲルマニウムの混合結晶を含み、第１の領域（１）のゲルマニウム含有率および厚さは、半導体デバイスに蓄積される電圧が、不整合転位が発生するレベルよりも小さく維持されるように選択される。意外にも、このようなデバイスは、非常に高速にスイッチングでき、公知のデバイスよりも高速にスイッチングできることが判明している。不整合転位が生じないことは付加的な利点を有する。すなわち、デバイスが非常に信頼性を有することである。不整合転位は、第１の領域の格子定数の前記相対的偏差および厚さの積が４０ｎｍ％以下ならば生じない。前記積の安全な上限値は３０ｎｍ％である。
Patent MD-20080045-A (MD)
Title: Process for increasing the critical currents in superconductig magnesium diboride
Inventor: SIDORENKO ANATOL
IPC: C01B35/00
Filed: 2008-02-15
Abstract: The invention relates to the field of electrical power engineering and cryoelectronics, and can be used in the superconductor study of materials.The process for increasing the critical currents in superconducting magnesium diboride consists in that on the surface of the magnesium diboride film there are deposited nanoparticles of magnetic material, for example, cobalt, which are powerful pinning centers, i.e. centers for vortex filament fixation into a superconductor, placed into a magnetic field.The result of the invention consists in increasing the critical current of the magnesium diboride pinning.
Patent NZ-207147-A (NZ)
Title: Adhesive bandage containing medicinal substance: pad and base prepared from bulky, non-woven material
Inventor: LAURITZEN N J
IPC: A61F13/02
Filed: 1984-02-14
Abstract: Adhesive bandages comprising a blister pad and adjacent adhesive-coated areas are prepared from heat-fusible bandage materials, preferably a nonwoven batt material, by applying the pad material to a base material and heatwelding around the perimeter of the pad to totally enclose the interior thereof. The portions of the base material extending from the pad area are compacted under heat and pressure to provide a surface suitable for a coating with adhesive. A medicated gel or other therapeutic material may be included within the confines of the pad area to provide a medicated blister bandage.
Patent NZ-207603-A (NZ)
Title: Polish compositions containing emulsion copolymers
Inventor: ZDANOWSKI R E
IPC: C09G1/16
Filed: 1984-03-23
Abstract: Polymer compositions which are useful as polishes or polish polymer vehicles, especially floor polishes or vehicles therefor, contain emulsion copolymer containing from 3% to 50% by weight of units of acidic monomer, transition metal ionic crosslinking agent in an amount of at least 15% of the equivalent of the copolymer acid residues, and at least one basic salt or hydroxide or alkali metal in such an amount that the molar ratio of transition metal to alkali metal is from 10:0.1 to 1.0:3.0. 
<??>The presence of the alkali metal compound increases the wear resistance properties of films of the polish.
Patent NZ-208325-A (NZ)
Title: Radiation-sensitive compositions containing heat-sensitive dyes
Inventor: FOLKARD C W
IPC: G03F7/105
Filed: 1984-05-30
Abstract: Radiation sensitive compositions are image-wise exposed and developed to form an image which is then heated to improve its strength as a lithographic printing image or etch resist. The heating is carried out in the presence of a heat sensitive dye which undergoes a colour change at a temperature of at least 180°C so as to obtain an indication of whether or not the heating has been adequate. The dye may be an integral component of the composition or it may be applied to the image, after development, in combination with a substance capable of forming a shield against contaminating residues produced during the heating step.
Patent NZ-223234-A (NZ)
Title: Fungicidal compositions and compounds
Inventor: CLOUGH J M
IPC: C07C323/62
Filed: 1988-01-19
Abstract: Fungicidal compounds of the formula (I) : <CHEM> and stereoisomers thereof, wherein R<1> is optionally substituted aryl or optionally substituted heteroaryl; Y is oxygen, sulphur or NR<4>; R<2>, R<3> and R<4>, which may be the same or different, are hydrogen, C1-4 alkyl or C2-4 alkenyl; X is halogen, C1-4 alkyl, C2-4 alkenyl, C1-4 alkoxy, nitro or cyano; and n is 0 or an integer of 1 to 4; provided that when Y is oxygen, n is 0 and R<1> is unsubstituted phenyl at least one of R<2> and R<3> is other than hydrogen or methyl.
Patent NZ-237723-A (NZ)
Title: Oligonucleotide analogues containing sulphur; intermediates; block multi-mer phosphoramidite compounds; pharmaceutical compositions
Inventor: HUIE EDWARD MCDONALD
IPC: A61K48/00
Filed: 1991-04-08
Abstract: Oligonucleotides possessing at least one sulfamate or sulfamide internucleotides linkages. These compounds can be used as specific hybridization probes to detect complementary nucleic acid sequences.
Patent NZ-242143-A (NZ)
Title: Apparatus for refuelling gas fuel tank; part of pressurised gas tank is load-bearing part for compressor housing
Inventor: BAUMANN HEINZ
IPC: F17C5/00
Filed: 1992-03-26
Abstract: A compressor (1) can be connected on the suction side via a suction line (7) provided with an inlet valve (16) to a natural gas line (9) and on the pressure side via an intake line (12) to the gas fuel tank (13) and is also connected via a relief line (10) to a relief valve (11) and a pressure control valve. (25), with said valves being disposed in a pressurized tank (4). This tank is connected to the suction side of the compressor (1) and the outlet sides of the inlet valve (16) and of the relief valve (11) and also with an outlet line (18) via a safety valve (20), which can be set at a predetermined opening pressure of 2 to 3 bar, for example. The pressurized tank (4), is designed with a cover (5) constructed as a support part, on which the compressor (1) is mounted. The compressor (1) can be coupled via a vertical drive shaft (2) with a motor (3) disposed inside the pressurized tank (4). This arrangement permits a simple design of the pressurized tank (4) and a compact construction of ,the appliance, which is particularly intended for refueling motor vehicles.
Patent NZ-243896-A (NZ)
Title: Culturing thermophillic bacteria
Inventor: RAVEN NEIL DOUGLAS HAMMOND
IPC: C12M1/04
Filed: 1992-08-10
Abstract: A process is described for growth of thermophilic bacteria in essentially elemental-sulphur free medium at cell densities of 1 x 10<9> ml<-1> and above. Growth is under steady state conditions with continuous introduction into the medium of an inert gas to remove hydrogen and/or hydrogen sulphide. The process can be carried out in a gas lift reactor.
Patent NZ-277036-A (NZ)
Title: Transdermal application of pharmaceuticals with increased deuterium isotope ratio
Inventor: HOFFMANN HANS-RAINER
IPC: A61K9/00
Filed: 1994-12-06
Abstract: PCT No. PCT/EP94/04047 Sec. 371 Date Aug. 15, 1996 Sec. 102(e) Date Aug. 15, 1996 PCT Filed Dec. 6, 1994 PCT Pub. No. WO95/17188 PCT Pub. Date Jun. 29, 1995A drug for the release of active substances to the skin, which has an increased deuterium portion as compared to the natural isotope distribution.
Patent NZ-279645-A (NZ)
Title: Enzyme composition and method for reducing acylglycerol ester content in water
Inventor: JAQUESS PERCY
IPC: C09K23/42
Filed: 1995-01-06
Abstract: An enzyme composition of matter is disclosed for reducing the amount of acylglycerol esters in water comprising a lipase enzyme, a non-ionic emulsifying agent, a water soluble organic acid preservative and a water soluble stabilizer. The lipase enzyme can be used in conjunction with other enzymes. The non-ionic emulsifying agent can comprise an alcohol ethoxylate, the water soluble organic acid preservative can comprise sorbic acid and the water soluble stabilizer can comprise glycerol. A method for treating water containing acylglycerol esters with the foregoing compositions is also disclosed.
Patent NZ-281340-A (NZ)
Title: Melamine preparation; separation of impurities
Inventor: VAN WIJCK JULIUS GERARDUS THEO
IPC: C07D251/60
Filed: 1995-03-07
Abstract: Disclosed is an improved method for separating impurities from a hot synthesis gas mixture which is obtained in the preparation of melamine and urea. The improved separation is achieved by use of filters made of sintered, essentially pure chromium, molybdenum, tungsten, or a mixture of any of these elements.
Patent NZ-334646-A (NZ)
Title: Mammalian REC2 genes and their promoters
Inventor: HOLLOMAN WILLIAM K
IPC: C12N9/00
Filed: 1997-09-11
Abstract: Over expression of REC2 in a cell is found to facilitate homologous recombination, particularly homologous recombination using a DNA/RNA chimericoligonucleotide and to sensitize a cell to the apoptotic effects of irradiation. The REC2 promoter, in combination with a strong enhancer, e.g., a SV40 enhancer, was found to be a strong promoter following irradiation of the cells. A radiation induceable promoter can be used to sensitize a cell to radiation treatment by operably linking the radiation induceable promoter to a gene whose expression converts a prodrug to a drug such as a herpes thymidine kinase gene
Patent NZ-337005-A (NZ)
Title: Multicompartment thermoplastic bag, the compartments being attached together along the tops, the bottom edges free
Inventor: SAAD ZAIN E M
IPC: A44B19/16
Filed: 1998-01-09
Abstract: A reclosable, thermoplastic bag 10 has at least two compartments 15, 16.  Each compartment has a top, a bottom edge 17, 18, side edges, and two opposing sidewalls joined at the side edges and the bottom edge.  Each compartment has a closure 31, 32 across the top thereof, which are arranged back-to-back and aligned such that the center points of each closure are less than 1/2 inch (1.27 cm) away from each other.  The compartments are attached together proximate the tops of the compartments, and the bottom edges of the compartments are free from being attached to each other.  The compartments may be attached proximate to the tops by a folded section of plastic film, an adhesive, a heat seal, an ultrasonic seal, an extruded lamination or a combination thereof.
Patent NZ-337084-A (NZ)
Title: Method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids and cyano or sulphonyl substituted spiro-oxiranyl-cyclohexane intermediates
Inventor: ALLEN ANDREW
IPC: C07C253/30
Filed: 1998-02-12
Abstract: A method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids of formula I comprises treating a compound of formula II with a Lewis acid in an aqueous solvent at a temperature between about 60 and 100oC, optionally under an inert atmosphere for a time sufficient for the reaction to go to completion. In formulae (I) and (II): R1 is -(CR4R5)nC(O)O(CR4R5)mR6, -(CR4R5)nC(O)NR4(CR4R5)mR6, -(CR4R5)nO(CR4R5)mR6 or -(CR4R5)rR6 wherein the alkyl moieties may be optionally substituted with one or more halogens; m is 0 to 2; n is 1 to 4; r is 0 to 6; R4 and R5 are independently hydrogen or alkyl; R6 is hydrogen, methyl, hydroxyl, aryl, halo substituted aryl, aryloxy alkyl, halo substituted aryloxy alkyl, indanyl, indenyl, polycycloalkyl, tetrahydrofuranyl, furanyl, tetrahydropyranyl, pyranyl, tetrahydrothienyl, thienyl, tetrahydrothiopyranyl, thiopyranyl, cycloalkyl or cycloalkyl containing one or two unsaturated bonds, wherein the cycloalkyl and heterocyclic moieties may be optionally substituted by 1 to 3 methyl groups or one ethyl group; provided that: a) when R6 is hydroxyl, then m is 2; b) when R6 is hydroxyl, then r is 2 to 6; c) when R6 is 2-tetrahydropyranyl, 2-tetrahydrothiopyranyl, 2-tetrahydrofuranyl, or 2-tetrahydrothienyl, then m is 1 or 2; d) when R6 is 2-tetrahydropyranyl, 2-tetrahydrothiopyranyl, 2-tetrahydrofuranyl, or 2-tetrahydrothienyl, then r is 1 to 6; or e) when n is 1 and m is 0, then R6 is other than H in -(CR4R5)nO(CR4R5)mR6, X is YR2, halogen, nitro, NH2, or formyl amine; X2 is O or NR8; Y is O or S(O)m'; m'  is 0 to 2; R2 is independently -CH3 or -CH2CH3 optionally substituted by 1 or more halogens; R3 is hydrogen, halogen, alkyl, CH2NHC(O)C(O)NH2, halo-substituted alkyl, -CH=CR8'R8', cyclopropyl optionally substituted by R8', CN, OR8, CH2OR8, NR8R10, CH2NR8R10 C(Z')H, C(O)OR8, C(O)NR8R10, or CºCR8'; R8 is hydrogen or alkyl optionally substituted by one to three fluorines; R8' is R8 or fluorine; R10 is OR8 or R11; R11 is hydrogen or alkyl optionally substituted by one to three fluorines; Z' is O, NOR8, NCN, C(-CN)2, CR8CN, CR8NO2, CR8C(O)OR8, CR8C(O)NR8R8, C(-CN)NO2, or C(-CN)C(O)NR8R8; R' and R" are independently hydrogen or -C(O)OH. A compound of formula II(a) or II(b)or of formula (Z), (IV) or (VI)  wherein R1, R3 and  X2 are as defined above is disclosed.
Patent NZ-337955-A (NZ)
Title: Modified TNF-alpha and their use as vaccines
Inventor: JENSEN MARTIN ROLAND
IPC: C12N15/11
Filed: 1998-04-15
Abstract: The specification describes a modified human TNF alpha molecule capable of raising neutralizing antibodies towards wild-type human TNF alpha.  The modification involves the substitution by at least one peptide known to contain an immunodominant T cell epitope; or a truncated form of the molecule containing an immunodominant epitope and one or both flanking regions of the human TNF alpha molecule comprising at least one TNF alpha B cell epitope.  The substitution introduces a substantial change in the amino acid sequence of the front beta -sheet, in any one of the connecting loops and/or in any one of the B', I or D strands of the back beta -sheet. The modified human TNF alpha molecules or DNA encoding them may be formulated as vaccines against TNF alpha optionally with pharmaceutically acceptable adjuvants.  The vaccines are reported to prevent or treat f chronic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel diseases, cancer, disseminated sclerosis, diabetes, psoriasis, osteoporosis or asthma. Human body fluids may be tested for the presence of TNF alpha by contact with a composition containing the modified TNF alpha .
Patent NZ-507810-A (NZ)
Title: Coin sorting method and device where the features of the coin are sensed and the coin identified as being either authentic or counterfeit
Inventor: ISHIDA TAKESHI
IPC: G07D5/02
Filed: 2000-02-24
Abstract: A coin sorter where the pattern on a coin slotted through a coin slotting part (2) is recognized by a sensor part (3).  The time during which the pattern is examined is measured by time measuring means (11).  The measured time is compared with a judgment value stored in judgment value storage means (16) so as to check whether the coin is genuine.
Patent NZ-508675-A (NZ)
Title: Method of and system for processing multicomponent seismic data
Inventor: MADTSON ERIC
IPC: G01V1/28
Filed: 1999-03-03
Abstract: Methods and systems are provided for orientation of multicomponent geophones, for rotating traces, and for correcting polarity differences between traces. According to an example embodiment, a receiver orientation angle is assigned, based on a determination of an angle between one or more horizontal components and one or more sources
Patent NZ-509328-A (NZ)
Title: Medicinal aerosol formulations
Inventor: KELLER MANFRED
IPC: A61K31/40
Filed: 1999-07-22
Abstract: A pressure-liquified propellant mixture for aerosols, containing dinitrogen monoxide and a hydrofluoroalkane of the formula: CxHyFz wherein x is 1, 2 or 3; y and z are each an integer > 1; and y + z = 2x + 2. The mixture improves the wetting properties for pharmaceutical active ingredients in medicinal aerosol formulations.
Patent NZ-509419-A (NZ)
Title: Process for the preparation of restructured meat having a layered structure
Inventor: FRADIN CHRISTIAN
IPC: A23L13/60
Filed: 1999-07-20
Abstract: A  method  consisting in breaking down a  muscle  into chunks,  forming  blocks in a mould  (4)  from  said  chunks whereof  the  surface  has been first  cooled,  slicing  the block   in   a   slicing  station  (7)  along  a   direction perpendicular  to  their length, to obtain superfine  films, with  a  surface of the order of 5 to 500 cm2,  a  thickness not  exceeding  a few tenths of mm, restructuring  the  meat into  one  piece  by  assembling the superfine  films  in  a vacuum   forming  device.  This  method  enables  to  obtain products  having a texture and sensory properties  close  to those of the natural product. Pieces  of  fresh meat are chilled (1) and  compacted  in  a press  (4)  then cut (TC) into thin slices of  5  to  30  mm thickness,  parallel  to  their  main  surface.  They   fall through  an  air  lock into an extruder  with  two  parallel helical screws.
Patent NZ-512085-A (NZ)
Title: Methods employing cyclic peptide antifungal agents
Inventor: DEBONO MANUEL
IPC: A61K38/12
Filed: 1993-03-15
Abstract: A method for inhibiting parasitic and fungal activity on a host body surface by contacting a target organism with acyl derivatives of the echinocandin class of cyclic peptide.  An organism of particular interest is Pneumocystis carinii.